Abstract
The increasing recognition and importance of fungal infections, the difficulties encountered in their treatment, and the increase in resistance to antifungal agents have stimulated the search for new therapeutic alternatives [1] . The essential oils and products of plant secondary metabolism had a wide application in folk medicine, fragrance industries, as well as food flavoring and preservation, but only in recent years they have started to be recognized for their potential antimicrobial role [2] [3] [4] . The literature reports evidence suggesting that a larger number of plants and their constituents could show beneficial therapeutic effects, including antioxidant, anti-inflammatory, and immunomodulatory activity, which still need to be further investigated [5] [6] [7] [8] [9] . In particular, data on the effects of essential oils on the innate immune system are scanty and fragmentary. As PMNs play a pivotal role against invading microbial pathogens, enhanced PMN activity under the essential oils influence may contribute to their anti-infective properties [10, 11] . The essential oil from Thymus vulgaris L. is widely used in folk medicine for the treatment of a variety of diseases since it possesses numerous biological properties including antibacterial, antifungal, and antioxidant activity [1, 3, [12] [13] [14] [15] [16] [17] . In this paper, we report the interaction of thyme (red) EO with human PMNs, focusing on intracellular killing of Candida albicans. As a positive control, we used fluconazole, one of the most common antifungal drugs in candidiasis management, known to enhance the fungicidal activity of PMNs [10] . Moreover, in order to provide a frame of reference for the activity of this EO, its in vitro killing in the absence of PMNs was also evaluated. EO MICs for C. albicans were 0.03 and 0.5 % v/v, while fluconazole MICs were 0.5 and 8 µg/mL with inocula of 10 3 and 10 6 ufc/mL, respectively. In the absence of PMNs, the EO activity was only fungistatic at all concentrations tested, causing slight reductions (i.e., ≤ 3 log 10 ) in the starting inoculum, as shown in l " Fig. 1 . At subMIC/MIC concentrations, killing activity was not sustained over time because yeast cell growth was seen at 24 h. Clinical experience showed that the efficacy of antimicrobial agents depends not only on their direct effect on a given microorganism but also on the functional activity of the immune system [10, 11, 18] . Results on effects upon the PMNs intracellular killing showed that EO and fluconazole had similar candidacidal activity (l " Table 1 ). EO at 1 × MIC significantly increased the intracellular killing by phagocytes, with percentages that ranged from 50 to 73 %, in comparison with controls (EO-free), ranging from 33 to 50 % (l " Table 1 ; p < 0.01). In the presence of 1 × MIC fluconazole, intracellular yeasts were killed at 51-69-75 % (p < 0.01). A similar picture was detected even at lower levels of EO (1/ 2 × MIC), where killing values (44-57-69 %) were significantly higher than those of control systems (33-47-50%; p < 0.05) and overlapped with those observed in presence of 1/2 × MIC fluconazole (42-58-63%). The mechanism of such enhancement is still unknown; despite the fact that this EO displayed only a fungistatic action in the absence of PMNs, it showed efficacy in killing yeasts once simultaneously incubated with PMNs, suggesting a positive antifungal interaction with phagocytes, as previously observed with other antifungal agents [10, 19] . EO direct damage to the yeast cell may be, at least in part, responsible for changes that make the yeasts more susceptible to PMN lytic mechanisms. The EO used in this study is mainly composed of thymol, ρ-cymene, limonene, α-pinene, carvacrol, and γ-terpinene, at different percentages [3] , but it is not clear which of the active ingredients accounted for the observed effect on yeast killing. Recent literature data reported that thymol and carvacrol exhibit fungicidal activity in a dose-dependent fashion against yeasts, resulting from direct damage to cell membranes [20] . Since essential oils are phytocomplexes containing numerous molecules, their bioactivity could be the result of a synergism of all major and minor components [21, 22] . In fact, antifungal susceptibility testing on thymol and carvacrol showed that these components exhibited MIC values higher (0.06% v/v) than those obtained with whole EO (0.03 % v/v) against C. albicans (data not shown). Further investigations are needed to confirm these findings.
Materials and Methods

!
A clinical C. albicans strain was isolated from blood, identified by conventional methods and subcultured on Sabouraud dextrose agar (SAB). Yeasts cultures consisted entirely of blastoconidia and had a slight tendency to differentiate into pseudohyphae during the course of the experiments [10] . The thyme (red) EO commercially obtained from Azienda Agricola Aboca was the same batch used and characterized by GC-FID analyses in a previous study [3] . Its major constituents were thymol (26.5%), ρ-cymene (16.2 %), limonene (13.2 %), α-pinene (13.2 %), carvacrol (7.8 %), and γ-terpinene (4%). Antifungal susceptibility testing was based on the CLSI M27-A3 [23] method, with some modifications; the final EO concentrations ranging from 1 to 0.0019 % (v/v). EO and fluconazole (Sigma-Aldrich; purity ≥ 98 % by HPLC) MIC values for C. albicans were determined with an inoculum of 10 3 cfu/mL and an inoculum of 10 6 cfu/mL to perform tests with and without phagocytes. In vitro killing was performed by using a . EO-free controls were included. 500 µL aliquots were removed at 0, 30, 60, 90, 120, 180 min, and 24 h, serially tenfold diluted and plated onto SAB agar. After 24-48 h at 37°C, results were reported as log cfu/mL. Fungicidal activity was defined as a 99.9 % (≥ 3 log 10 ) reduction in viable cell counts as compared with the starting inoculum [11] .
Human PMNs were separated from lithium heparinized venous blood using Ficoll-Paque (Pharmacia S. p. A.) and adjusted to 10 6 cells/mL in RPMI1640 [11] . Viability, determined by trypan blue exclusion, was greater than 95%. The EO effect on the intracellular killing of C. albicans by PMNs was investigated by incubating blastoconidia (10 6 cfu/mL) and PMNs (10 6 cells/mL) for 30 min to allow phagocytosis to proceed. The PMN-yeast cell mixtures were centrifuged at 200 g for 5 min to remove extracellular blastoconidia. An aliquot of PMNs was lysed by adding sterile water, and intracellular viable yeast counting was performed (time zero). PMNs were incubated further with 0.25 % v/v and/or 0.5 % v/v (1/2 MIC and 1 × MIC, respectively) of EO and at time X (30, 60, 90 min), the viable counts were measured in the same way. EO-free controls were included. As positive controls, 1/2 × MIC (4 µg/mL) and 1 × MIC (8 µg/mL) fluconazole were included. Killing values were expressed as a survival index (SI), which was calculated by adding the number of surviving blastoconidia at time zero to the number of survivors at time X and dividing by the number of survivors at time zero. According to this formula, if fungal killing was 100 % effective, the SI would be 1 [10, 11] . Results are expressed as the mean ± standard error of the mean (SEM) of 10 separate experiments, each performed in quadruplicate. Statistical evaluation of the differences between test and control results was performed by Tukeyʼs test. In vitro killing was compared using Studentʼs unpaired t-test. 
